@pub2post.bsky.social2026 Consensus Report on Type 2 Diabetes Management.
๐ Emphasizes holistic care approach.
๐ฟ Encourages healthy lifestyle practices.
๐ Early use of SGLT2 inhibitors & GLP-1 therapies.
๐ https://dev.tnyp.me/a6uuLaC0/s #ADA #EASD #Diabetes
@idfe.bsky.social๐ฌ Check your emails! Our September #newsletter is out!
๐ Read our editorial on #EUScreeningWeek
๐ฃ Learn about our our #EASD Symposium on diabetes education
๐ฐ Stay informed with health-related #news
๐ฌ Discover updates from our #researchprojects
โก createsend.com/t/t-2DA89DF2...
@aiinmeditech.bsky.socialWhat makes EASD influential among diabetes experts?
Our latest KOL study examines scientific credibility, emerging treatment evidence, clinical influence, and future opportunities.
Explore the findings:
www.sperresearch.com/Case-Studies...
@nursinginpractice.bsky.socialHealthcare professionals should routinely discuss the emotional impact of diabetes with patients, according to a clinical practice guideline developed by the European Association for the Study of Diabetes (EASD).
@biotechhangout.bsky.social#BiotechHangout Graig Suvannavejh, Sam Fazeli, Eric Schmidt & Brian Skorney on biotech market review & IPOs, $MRNA on Nasdaq 100, deals: $AZN/$SMMT, AZN-Daiichi-$SMMT, $NVO/Hengrui, $REGN/$SNY, company news: $MIRM, $ABBV, $MRK, data: $DYN, $MIRM, $KOD, $IMMX, $QURE, #EASD, #WCLC, #AAO bit.ly/3TFmfQK
@newsen.bsky.socialEASD 2026: Phase III Results of Olatorepatide Show Significant Weight Loss Benefits #Italy #Milan #Hansoh_Pharma #EASD #Olatorepatide
@newsen.bsky.socialSignificant Weight Loss Achieved with Olatorepatide in Phase III Study Presented at EASD 2026 #Italy #Milan #Hansoh_Pharma #EASD #Olatorepatide
@pharmaphorum.bsky.socialAs the #EASD congress draws to a close, here's a round-up of some of the other #clinicaltrials in #diabetes and #obesity that drew our attention.
@metabologiajnl.bsky.social#EASD/#EFSD Rising Star 2026 Carla Horvath (@ETH Zurich, @D-HEST) explores how menopausal oestrogen loss rewires adipocytes, shifting lipid storage and raising risk of type 2 diabetes and #MASLD. #Menopause #AdiposeTissue link.springer.com/article/10.1...
@metabologiajnl.bsky.social2026 #EASD/#EFSD Rising Star @Sara Stinson examines multi-omic trajectories of #Alzheimer's disease, revealing a shared geneticโmetabolic signature with #Type2Diabetes. #T2D #MultiOmics #OsloUniveristyHospital #UniversityofOslo link.springer.com/article/10.1...
@metabologiajnl.bsky.social2026 #EASD/#EFSD Rising Star @AaronNovikoff brings to light novel strategies in anti-obesity #incretin pharmacology, redirecting focus away from poly-receptor agonism and towards the untapped potential of precision pharmacodynamics. #AntiObesity #Pharmacology link.springer.com/article/10.1...
@metabologiajnl.bsky.socialAdults with single islet #autoantibodies who develop diabetes donโt all follow same path; some need early #insulin, others don't. 2026 #EASD/#EFSD Rising Star Nicholas Thomasโ research investigates whoโs at greatest risk of needing insulin & how to predict this link.springer.com/article/10.1...
@newsen.bsky.socialSinocare Unveils Comprehensive Chronic Disease Management Solutions at EASD 2026 Conference #Italy #Milan #Chronic_Disease #Sinocare #EASD
@financiernews.bsky.social๐ฅ Lilly Slides 2% As EASD Deck Lands With No New Guidance
Eli Lilly presented at the 2026 EASD annual meeting, publishing a slide deck tied to the event.
Shares fell 2.02% to 1,160.75, holding the 82nd percentile of the 52-week range after a 7.44% YTD run.
@lc-stene.bsky.social
@explora-guide78.bsky.socialThere is more to Milan than the conference programme.
Turns the gaps between sessions into a self-guided discovery trail through the cityโs history.
Special Collection Code: DIABETES-MILAN
@ispadsociety.bsky.socialA new international consensus report endorsed by #ISPAD, #EASD and #ADA provides guidance across the full transition of care continuum while recognizing the need to adapt these recommendations to local settings.
๐ Read the full consensus report: https://loom.ly/Wel8FXE
@easdnews.bsky.social๐ข๐ค๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐: Join Prof. Dame Melanie Davies & Prof. John Buse at #EASD2026 in Milan for the " #ADA / #EASD consensus report on the management of type 2 #diabetes"๐ฎ๐น
๐ Fri, 2 Oct 2026 | 13:00 CEST |๐London Hall
Learn more ๐ pagv3.virtual-meeting.org/EASD/easd202...
@diabetologiajnl.bsky.socialReview of 248 RCTs: #DiabetesDistress can be reduced. Psychological support helps in type 1 & type 2 #Diabetes, CGM lowers distress in type 1 diabetes, & education works in type 2 diabetes. Targeted strategies matter link.springer.com/article/10.1... #MentalHealth #DiabetesCare #EASD ๐๏ธ